Parkinson's Support Group Paper

This paper is an in depth examination of a family and their experiences involving a loved ones, further referred to as R.M., diagnosis with early onset Parkinson’s disease. The information for this paper was gathered through three unstructured interviews, with three different family members, taken independently over several days. These interviews revealed the family’s developmental life cycle stage over many years, the illness narratives from three different perspectives, and the effects of this illness on each of the different family members. K.M., R.M.’s daughter, experienced the greatest impact from her father’s diagnosis with early onset Parkinson’s disease. L.M., K.M.’s husband, offered the perspective from a non immediate family member who struggled with the effects that R.M.’s disease had on his wife, and the daunting task of watching the rapidly deteriorating physical abilities of R.M. T.M., the son of K.M. and L.M., described his unique experiences of seeing his grandfather sick and the effects this had on him at such a young age. A genogram and ecomap are included in the paper to provide an illustrative representation of the relationships within the family, as well as the various systems that have had an impact on this illness experience, such as the family’s involvement with the health care system.

For many 50 year olds, tasks such as writing or walking can be easily preformed without much attention. In fact, the term “task” seems to stress that there is a greater level of effort than is truly exerted in order for the average person to perform these actions. However, for a patient of Parkinson’s Disease who is diagnosed on average at the age of 50, these every day activities take a great deal of time, attention, and effort to be preformed (Huston). With the growth of research about this disease, a variety of treatment options ranging from medication to surgery are currently available to patients who suffer from the debilitating effects of Parkinson’s Disease.

Acosta, S. A., Tajiri, N., de la Pena, I., Bastawrous, M., Sanberg, P. R., Kaneko, Y., & Borlongan, C. V. (2015). Alpha-Synuclein as a Pathological Link Between Chronic Traumatic Brain Injury and Parkinson's Disease. Journal Of Cellular Physiology, 230(5), 1024-1032. doi:10.1002/jcp.24830.

Parkinson’s is a disease where patients do not have enough dopamine, because some of their nerve cells have died in the brain. Dopamine controls the movement in the body, and without it movement becomes slow. Treatments for Parkinson’s are used to control the symptoms. This disease is not well known because patients do not generally die from Parkinson’s. As Parkinson’s progresses the symptoms get worse and can cause other health issues. I used current research papers and information found pertaining to different Parkinson’s organizations to argue the point that Parkinson’s does not have enough awareness and funding for scientists to find a cure.

New discoveries on the treatment of Parkinson’s disease show that dopamine neurons can treat Parkinson’s disease. Parkinson’s disease is a disorder of the nervous system, which is a progressive disease. Parkinson’s disease is marked by tremors, muscular stiffness. It mainly affects people who are either elderly or middle aged. Although Parkinson’s disease cannot be cure lab grown dopamine can assist in being able to manage the disease in an enhanced way. Although Parkinson’s disease is not curable but can be treatable it still needs more work in order to make a cure in the future. Dopamine helps regulate movement and when there is a deficiency in dopamine that results in Parkinson’s disease.

Parkinson’s Disease (from hereon PD) is an extrapyramidal disorder characterized primarily by massive idiopathic degeneration of dopaminergic neurons in the substantia nigra, resulting in greatly decreased levels of dopamine in the striatum. The diagnosis, which is essentially a clinical judgment due to the lack, thus far of a simple diagnostic test, has historically been on the basis of the presence of at least two of the three main features of PD: bradykinesia (or akinesia or hypokinesia), rigidity, and resting tremor. In addition to these symptoms, most PD patients also show postural disturbances, impaired righting reflexes, and abnormal ocular movements. The extent of the disease and its symptoms can be quantified by one of a few

Parkinson’s disease is a common form of Parkinsonism, affecting as many as one out of every hundred people aged 65 years and over. The disease prevalence increases with age, with

In “The effects of physical therapy in parkinson's disease”, De Goede, Samyra, Keus, Gert Kwakkel, & Wagenaar describes the effects of physical therapy towards patients with Parkinson’s disease. De Goede et al include both physical therapy approaches, and the medication used to help those with Parkinson’s. Physical therapy (PT) has a great impact for individuals struggling with PD. But the results of Physical therapy do not help a patient completely rid of the symptoms with PD.

Parkinson’s disease (PD), is degenerative disease of the brain affects parts of the brain that are associated with normal movement and balance. The mechanism of PD start by the loss of brain cells that produce dopamine in substantia nigra. Dopamine is a neurotransmitter or chemical messenger that carries signals between the neurons in the brain. The etiology of PD is idiopathic, and it is supposed to be due to many factors such as age, genetics, and environmental factors such as pesticides(5).

This is a article about how neuroscientist may have discovered a way to slow down the progression of Parkinson's disease. Parkinson's disease affects over 1 million people in the United States. Parkinson disease is a progressive disease that affects the nervous system. With this condition, you experienced tremors,muscular rigidity and slow and precise movements. The effects of disease is associated with degeneration of the basal ganglia of the brain and the deficiency of the neurotransmitter dopamine. According to the neurosciences Gary W.Miller PhD. An unequaitable double amount of dopamine stored can be extremely harmful to the neurons in

Parkinson's disease is a progressive nervous system disorder that affects your movement. It is gradual and sometimes starts with a tremor that is barely noticeable in just a hand. A tremor is the usual sign of Parkinson's disease, but Parkinson’s can also causes stiffness or slowing of movement.

Doctor Smith and Doctor Helen, were running the blood tests to check for abnormal thyroid, which would let us know if you could have certain symptoms tracing to Parkinson’s disease (PD), and unfortunately the results came back as positive. Approximately 15 percent of people with Parkinson’s disease have a family history of this disorder. Parkinson’s disease (PD), is caused by mutations in the LRRK2, PARK7, PINK1, PRKN, or SNCA gene, or by adjustments in genes that have not been identified; therefore, this disease is classified as a gene mutation. Inheriting this disease is in fact rare. This disease is known to be idiopathic, which means that the exact cause is not yet known.

Management of the patient with Parkinson’s syndrome is directed towards controlling the symptoms with physical therapy and drug therapy. The most beneficial physical therapy programs incorporate massage, heat, exercise, and gait retraining. Speech therapy has been used with swallowing issues, as well as difficulty with speech with variable results. Drug therapy relieves many of the symptoms of the disease. Early in the course of disease, dopamine receptor agonist pramipexole(mirapex) or ropinirole (reqip) are used to maximize the intrinsic dopamine. The corner stone of therapy is the use of L-dopa (l-dihydroxyphenylalanine). L-dopa can cross the blood-brain barrier and is converted to dopamine in the basal ganglia, thereby supplementing levels

Parkinson’s Disease is a very common disorder found all over the world. There are around 20 new cases per 100,000 people are diagnosed with Parkinson’s disease every year. That’s not counting to the people that have it undetected. An estimated 7 to 10 million people live with this terrible disease around the world. People such as Michael J. Fox, Marty, from the Back to the Future movies, Muhammad Ali the famous boxer, and Johnny Cash the famous singer. Parkinson’s disease is an awful disease that affects patients’ minds and bodies in terrible ways.

Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by loss of striatal dopaminergic (DA) terminals and progressive degeneration of dopaminergic neurons in the substantia nigra pars campocta (SNpc) [1]. There is growing evidence suggesting the role of chronic, uncontrolled inflammation in many neuro degenerative disorders[4-7] [1-7] and the effect of anti-inflammatory drugs in altering the course of the disease further supports this idea [8][8]. The inflammation in CNS is mostly the result of innate immune response caused my microglia, cytokines and complement proteins [9][9]. The pathological characteristic of PD is deposits of aggregated α-synuclein in intracellular inclusions, called Lewy bodies [2, 3], which can